276 related articles for article (PubMed ID: 30253786)
1. LGI1 expression and human brain asymmetry: insights from patients with LGI1-antibody encephalitis.
Jang Y; Lee ST; Bae JY; Kim TJ; Jun JS; Moon J; Jung KH; Park KI; Irani SR; Chu K; Lee SK
J Neuroinflammation; 2018 Sep; 15(1):279. PubMed ID: 30253786
[TBL] [Abstract][Full Text] [Related]
2. Subcortical Hypermetabolism Associated With Cortical Hypometabolism Is a Common Metabolic Pattern in Patients With Anti-Leucine-Rich Glioma-Inactivated 1 Antibody Encephalitis.
Zhao X; Zhao S; Chen Y; Zhang Z; Li X; Liu X; Lv R; Wang Q; Ai L
Front Immunol; 2021; 12():672846. PubMed ID: 34616389
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune encephalitis associated with voltage-gated potassium channels-complex and leucine-rich glioma-inactivated 1 antibodies - a national cohort study.
Celicanin M; Blaabjerg M; Maersk-Moller C; Beniczky S; Marner L; Thomsen C; Bach FW; Kondziella D; Andersen H; Somnier F; Illes Z; Pinborg LH
Eur J Neurol; 2017 Aug; 24(8):999-1005. PubMed ID: 28544133
[TBL] [Abstract][Full Text] [Related]
4. Recognition of seizure semiology and semiquantitative FDG-PET analysis of anti-LGI1 encephalitis.
Li TR; Zhang YD; Wang Q; Shao XQ; Lv RJ
CNS Neurosci Ther; 2021 Oct; 27(10):1173-1181. PubMed ID: 34291554
[TBL] [Abstract][Full Text] [Related]
5. Motor cortex and hippocampus are the two main cortical targets in LGI1-antibody encephalitis.
Navarro V; Kas A; Apartis E; Chami L; Rogemond V; Levy P; Psimaras D; Habert MO; Baulac M; Delattre JY; Honnorat J;
Brain; 2016 Apr; 139(Pt 4):1079-93. PubMed ID: 26945884
[TBL] [Abstract][Full Text] [Related]
6. Anti-leucine rich glioma inactivated 1 protein and anti-N-methyl-D-aspartate receptor encephalitis show distinct patterns of brain glucose metabolism in 18F-fluoro-2-deoxy-d-glucose positron emission tomography.
Wegner F; Wilke F; Raab P; Tayeb SB; Boeck AL; Haense C; Trebst C; Voss E; Schrader C; Logemann F; Ahrens J; Leffler A; Rodriguez-Raecke R; Dengler R; Geworski L; Bengel FM; Berding G; Stangel M; Nabavi E
BMC Neurol; 2014 Jun; 14():136. PubMed ID: 24950993
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics and short-term prognosis of LGI1 antibody encephalitis: a retrospective case study.
Li W; Wu S; Meng Q; Zhang X; Guo Y; Cong L; Cong S; Zheng D
BMC Neurol; 2018 Jul; 18(1):96. PubMed ID: 29980179
[TBL] [Abstract][Full Text] [Related]
8. VGKC-complex/LGI1-antibody encephalitis: clinical manifestations and response to immunotherapy.
Shin YW; Lee ST; Shin JW; Moon J; Lim JA; Byun JI; Kim TJ; Lee KJ; Kim YS; Park KI; Jung KH; Lee SK; Chu K
J Neuroimmunol; 2013 Dec; 265(1-2):75-81. PubMed ID: 24176648
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Cognitive Deficits and Structural Hippocampal Damage in Encephalitis With Leucine-Rich, Glioma-Inactivated 1 Antibodies.
Finke C; Prüss H; Heine J; Reuter S; Kopp UA; Wegner F; Then Bergh F; Koch S; Jansen O; Münte T; Deuschl G; Ruprecht K; Stöcker W; Wandinger KP; Paul F; Bartsch T
JAMA Neurol; 2017 Jan; 74(1):50-59. PubMed ID: 27893017
[TBL] [Abstract][Full Text] [Related]
10. [A case of smoldering anti-leucine-rich glioma-inactivated 1 (LGI1) antibody-associated limbic encephalitis with faciobrachial dystonic seizure].
Nakaoku Y; Maki T; Kanazawa K; Matsumoto R; Fukuyama H; Takahashi R; Ikeda A
Rinsho Shinkeigaku; 2013; 53(9):706-11. PubMed ID: 24097318
[TBL] [Abstract][Full Text] [Related]
11. Cortical and Subcortical Dysmetabolism Are Dynamic Markers of Clinical Disability and Course in Anti-LGI1 Encephalitis.
Rissanen E; Carter K; Cicero S; Ficke J; Kijewski M; Park MA; Kijewski J; Stern E; Chitnis T; Silbersweig D; Weiner HL; Kim CK; Lyons J; Klein JP; Bhattacharyya S; Singhal T
Neurol Neuroimmunol Neuroinflamm; 2022 Mar; 9(2):. PubMed ID: 35091466
[TBL] [Abstract][Full Text] [Related]
12. The Clinical Value of
Liu X; Shan W; Zhao X; Ren J; Ren G; Chen C; Shi W; Lv R; Li Z; Liu Y; Ai L; Wang Q
Front Neurol; 2020; 11():418. PubMed ID: 32581996
[No Abstract] [Full Text] [Related]
13. Magnetic Resonance Imaging Characteristics of LGI1-Antibody and CASPR2-Antibody Encephalitis.
Kelly MJ; Grant E; Murchison AG; Binks S; Ramanathan S; Michael S; Handel AE; Handunnetthi L; Uy CE; Soltys JN; Dubey D; Day GS; Lopez-Chiriboga AS; Flanagan EP; Sheerin F; Irani SR
JAMA Neurol; 2024 May; 81(5):525-533. PubMed ID: 38497971
[TBL] [Abstract][Full Text] [Related]
14. Clinical and electrographic characteristics of seizures in LGI1-antibody encephalitis.
Li LH; Ma CC; Zhang HF; Lian YJ
Epilepsy Behav; 2018 Nov; 88():277-282. PubMed ID: 30332659
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Superiority of 18 F-FDG PET Over MRI in Detecting Anti-LGI1 Autoimmune Encephalitis : A Comparative Study With Insights Into Faciobrachial Dystonic Seizures Mechanisms and Recurrence Identification.
Liang M; Niu N; Jia C; Fan S; Liu L; Cui R; Guan H
Clin Nucl Med; 2023 Nov; 48(11):e516-e522. PubMed ID: 37703438
[TBL] [Abstract][Full Text] [Related]
16. Frequent hemianesthesia as initial symptom of limbic encephalitis associated with LGI1 antibodies.
Gong J; Zhang Y; Wang F; Huang Y; Zhang W
Neurol Sci; 2015 Oct; 36(10):1953-5. PubMed ID: 26094002
[No Abstract] [Full Text] [Related]
17. [Ictal electroencephalography (EEG) activity and cerebral blood flow dynamics as potential pathological indicators: a case of anti-leucine-rich glioma-inactivated 1 protein (LGI1) encephalitis].
Ishibashi H; Neshige S; Aoki S; Ueno H; Iida K; Maruyama H
Rinsho Shinkeigaku; 2020 Nov; 60(11):778-785. PubMed ID: 33115994
[TBL] [Abstract][Full Text] [Related]
18. Rapidly Cycling Auras and Episodic Focal Dystonia in Anti-LGI1 Autoimmune Encephalitis.
Fantaneanu TA; Bhattacharyya S; Milligan TA; Pennell PB
JAMA Neurol; 2016 Sep; 73(9):1150. PubMed ID: 27399958
[No Abstract] [Full Text] [Related]
19. Episodic bradycardia as neurocardiac prodrome to voltage-gated potassium channel complex/leucine-rich, glioma inactivated 1 antibody encephalitis.
Naasan G; Irani SR; Bettcher BM; Geschwind MD; Gelfand JM
JAMA Neurol; 2014 Oct; 71(10):1300-4. PubMed ID: 25133690
[TBL] [Abstract][Full Text] [Related]
20. Flortaucipir (tau) PET in LGI1 antibody encephalitis.
Day GS; Gordon BA; McCullough A; Bucelli RC; Perrin RJ; Benzinger TLS; Ances BM
Ann Clin Transl Neurol; 2021 Feb; 8(2):491-497. PubMed ID: 33410601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
